You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Triple inhaler therapy for COPD
  1. Brian Lipworth
  1. Correspondence to Dr Brian Lipworth, Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK; b.j.lipworth{at}dundee.ac.uk

https://doi.org/10.1136/thoraxjnl-2015-207388

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The randomised controlled trial (GLISTEN) by Frith et al1 showed significant improvements in trough FEV1, health-related quality of life and rescue medication when long-acting muscarinic antagonists (LAMA: as either tiotropium or glycopyrronium) were added to inhaled corticosteroid/long-acting beta-agonist (ICS/LABA: as fluticasone/salmeterol) in 773 patients with moderate-to-severe COPD (FEV1 57.2%) over 12 weeks. The authors concluded that this was the first …

    View Full Text

    Footnotes

    • Competing interests BL has received support to attend BTS and ERS from Boehringer Ingelheim and has also received payment for attending advisory boards from Boehringer Ingelheim, Chiesi and Teva. The Scottish Centre for Respiratory Research has received unrestricted education grant funding from Almirall, Teva and Chiesi. Scottish Centre for Respiratory Research has received support to attend ERS from Teva and Chiesi.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • Chronic obstructive pulmonary disease
      Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
      Peter A Frith Philip J Thompson Rajeev Ratnavadivel Catherina L Chang Peter Bremner Peter Day Christina Frenzel Nicol Kurstjens the Glisten Study Group Ainslie Waddell Alexander Daniel Alireza Khoussousi Andrew Springfield Andrew Veale Anthony Neil Graham Brad Gallagher Braj Raj Pande Brendan O'Kane Christopher Jones Claudio Baldi Colin Helm Conor O'Dochartaigh Daniel Chambers Dean Quinn Derek Yull Dhanalakshi Karthigesu Edward Then Frank Graham Fred Faigenbaum Geetha Geddam Gillian Cameron Hans Blom Hershel Goldman Hilary Snell Imagard Chia James Jeong James Liew James Salvaris Jason Pryke Jim Reid John Kolbe John O'Sullivan John Pak John Upham Joseph Feiber Judith O'Malley Ford Kevin Yong Kyle Perrin Lawrence Noonan Len Atlas Louise Murdoch Margaret Pearce Mark Bloch Mark Holmes Michael Chia Michael Epton Michelle Leadston MK Tandon Mohan Chitgopeker Naomi Liebenberg Neil Hendry Olakunle Olaniyi Omesh Singh Peter Kendall Peter Van Niekerk Rodney Willet Ronald Tomlins Salven Pillay Sammy Sharifeh Simon Carson Stephen Bingham Ted Walford Tersia Erasmus Trevor Claridge Zofia Hess
      Thorax 2015; 70 519-527 Published Online First: 03 Apr 2015. doi: 10.1136/thoraxjnl-2014-206670